Carotid artery overtreatment in the USA
- PMID: 38372220
- DOI: 10.1016/S1474-4422(23)00407-6
Carotid artery overtreatment in the USA
Conflict of interest statement
AA has received grants for independent research on the topic of stroke prevention. However, she was not academically funded at the time of creating this manuscript. She is also the founding member of the Faculty Advocating Collaborative and Thoughtful Carotid Artery Treatments (FACTCAT). All authors are FACTCAT members. The views of particular FACTCAT members do not necessarily reflect the views of others. LS is a retired Medical Officer (2000–13) for the Coverage and Analysis Group, Office of Clinical Standards and Quality, Center for Medicare & Medicaid Services, Baltimore MD, USA; and was Lead Medical Officer for the Medicare Evidence Development & Coverage Advisory Committee, Management of Carotid Atherosclerosis, on Jan 25, 2012.
Comment in
-
Expansion of stenting indications in the USA.Lancet Neurol. 2023 Dec;22(12):1103. doi: 10.1016/S1474-4422(23)00408-8. Epub 2023 Oct 27. Lancet Neurol. 2023. PMID: 38372221 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources